These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3980324)

  • 21. Pharmacokinetics of antibiotics in tissues and tissue fluids: a review.
    Cars O
    Scand J Infect Dis Suppl; 1990; 74():23-33. PubMed ID: 2097711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New in vitro model to study the effect of human simulated antibiotic concentrations on bacterial biofilms.
    Haagensen JA; Verotta D; Huang L; Spormann A; Yang K
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4074-81. PubMed ID: 25918138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of cardiac output distribution on the tissue/plasma drug concentration ratio.
    Fagiolino P
    Eur J Drug Metab Pharmacokinet; 2002; 27(2):79-81. PubMed ID: 12064375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of antibiotics eliminated by first order kinetics.
    Bergan T; Carlsen IB
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():147-52. PubMed ID: 3980326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple-compartment pharmacokinetics of tobramycin.
    Kahlmeter G; Jonsson S; Kamme C
    J Antimicrob Chemother; 1978 May; 4 Suppl A():5-11. PubMed ID: 659350
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical limitations of in vitro testing of microorganism susceptibility.
    Nightingale J
    Am J Hosp Pharm; 1987 Jan; 44(1):131-7. PubMed ID: 3826085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of ascites on the pharmacokinetics of amikacin.
    Lanao JM; Dominguez-Gil A; Macias JG; Diez JL; Nieto MJ
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):57-61. PubMed ID: 7372376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro simulated pharmacokinetics profiles: forecasting antibiotic optimal dosage.
    Firsov AA
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():406-9. PubMed ID: 1820913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Methods for in vitro studies of antibiotic combinations. Indications and limits].
    Thabaut A; Meyran M
    Presse Med; 1987 Dec; 16(43):2148-52. PubMed ID: 2963301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Quantitative analysis of cell-kill effects of anticancer drugs: consideration of both in vitro and in vivo experimental systems].
    Sugiyama Y; Kobayashi T; Inaba M
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3183-98. PubMed ID: 3318699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of tissue distribution of antibiotics by kinetic hysteresis analysis.
    Ganzinger U; Neumann K
    Eur J Clin Pharmacol; 1992; 43(5):517-22. PubMed ID: 1483488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution and elimination kinetics of intravenously and intramusculary administered tobramycin in man.
    Péchère JC; Roy B; Dugal R
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):313-8. PubMed ID: 1002369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of in vitro antibiotic sensitivity: critical features of the MIC].
    Malcangi A; Mineccia C; Martinetto P
    G Batteriol Virol Immunol; 1989; 82(1-12):165-73. PubMed ID: 2518761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Penetration of antibiotics into peripheral infection foci].
    Bergan T
    Wien Klin Wochenschr; 1982 Jun; 94(13):331-40. PubMed ID: 7135978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of the pharmacokinetics of antimicrobial drugs.
    Hinderling PH
    Scand J Infect Dis Suppl; 1978; (14):25-35. PubMed ID: 279979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum level monitoring of antibacterial drugs. A review.
    Wenk M; Vozeh S; Follath F
    Clin Pharmacokinet; 1984; 9(6):475-92. PubMed ID: 6391780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro simulation of in vivo pharmacokinetic model with intravenous administration via flow rate modulation.
    Chen YC; Liang W; Hu JL; He GL; Wu XJ; Liu XF; Zhang J; Hu XQ
    J Pharmacokinet Pharmacodyn; 2015 Feb; 42(1):33-43. PubMed ID: 25354895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical studies of intravenous drip infusion of micronomicin. 1. Pharmacokinetics (Part 2). Intravenous Micronomicin Research Group].
    Watanabe M; Saito I; Mitsuhashi S; Koyama M; Kawaguchi Y
    Jpn J Antibiot; 1985 Apr; 38(4):1086-92. PubMed ID: 4032720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug combinations and impact of experimental conditions on relative recovery in in vitro microdialysis investigations.
    Burau D; Petroff D; Simon P; Ehmann L; Weiser C; Dorn C; Kratzer A; Wrigge H; Kloft C
    Eur J Pharm Sci; 2019 Jan; 127():252-260. PubMed ID: 30391402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetics of cefamandole in rabbits].
    Klimova VS; Bobrov VI; Nazarova OI; Skala LZ; Iakovlev VP
    Antibiotiki; 1982 Dec; 27(12):34-8. PubMed ID: 7165292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.